Novavax (NVAX) Net Margin (QoQ) (2010 - 2026)
Novavax (NVAX) Net Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,871.00 |
| Dec 31, 2025 | 29,920.00 |
| Sep 30, 2025 | -34,815.00 |
| Jun 30, 2025 | -1,694.00 |
| Mar 31, 2025 | 16,955.00 |
| Dec 31, 2024 | 5,177.00 |
| Sep 30, 2024 | -18,261.00 |
| Jun 30, 2024 | 19,629.00 |
| Mar 31, 2024 | -9,598.00 |
| Dec 31, 2023 | 871.00 |
| Sep 30, 2023 | -8,361.00 |
| Jun 30, 2023 | 37,673.00 |
| Mar 31, 2023 | -31,207.00 |
| Dec 31, 2022 | -2,804.00 |
| Sep 30, 2022 | 25,161.00 |
| Jun 30, 2022 | -30,346.00 |
| Mar 31, 2022 | 40,976.00 |
| Dec 31, 2021 | -20,058.00 |
| Sep 30, 2021 | -6,207.00 |
| Jun 30, 2021 | -6,842.00 |